{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:16:38Z","timestamp":1790403398342,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"France Parkinson Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbr.2017.06.016","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:33:10Z","timestamp":1497918790000},"page":"327-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Chronic pramipexole treatment induces compulsive behavior in rats with 6-OHDA lesions of the substantia nigra and ventral tegmental area"],"prefix":"10.1016","volume":"332","author":[{"given":"D.","family":"Dardou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Reyrolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chassain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Durif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2017.06.016_bib0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00002826-199704000-00005","article-title":"Psychiatric and sexual disorders induced by apomorphine in Parkinson\u2019s disease","volume":"20","author":"Courty","year":"1997","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0010","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/mds.21611","article-title":"Pathological gambling in Parkinson\u2019s disease: risk factors and differences from dopamine dysregulation. An analysis of published case series","volume":"22","author":"Gallagher","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2017.06.016_bib0015","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archneur.64.8.1089","article-title":"Medication-related impulse control and repetitive behaviors in Parkinson disease","volume":"64","author":"Voon","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.parkreldis.2007.09.007","article-title":"Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease","volume":"14","author":"Merims","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbr.2017.06.016_bib0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jns.2011.06.055","article-title":"Body weight gain and deep brain stimulation","volume":"310","author":"Rieu","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbr.2017.06.016_bib0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2017.06.016_bib0040","first-page":"81","article-title":"Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study","volume":"33","author":"Cornelius","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.bbr.2017.06.016_bib0045","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s00415-015-7722-7","article-title":"Single versus multiple impulse control disorders in Parkinson\u2019s disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release","volume":"262","author":"Wu","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0050","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","article-title":"Prospective prevalence of pathologic gambling and medication association in Parkinson disease","volume":"66","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2017.06.016_bib0055","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.102.039875","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)\/alpha(2)-adrenoceptor","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2017.06.016_bib0060","first-page":"37","article-title":"Side effects of a dopamine agonist therapy for Parkinson\u2019s disease: a mini-review of clinical pharmacology","volume":"89","author":"Borovac","year":"2016","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.bbr.2017.06.016_bib0065","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","article-title":"Impulse disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: a multicentre study","volume":"85","author":"Garcia-Ruiz","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbr.2017.06.016_bib0070","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bbr.2017.06.016_bib0075","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Milan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2017.06.016_bib0080","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2011.01.020","article-title":"Impulsivity, compulsivity, and top-down cognitive control","volume":"69","author":"Dalley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2017.06.016_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tics.2011.11.009","article-title":"Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry","volume":"16","author":"Robbins","year":"2012","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.bbr.2017.06.016_bib0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","article-title":"Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management","volume":"23","author":"O'Sullivan","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2017.06.016_bib0095","first-page":"55","article-title":"Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model","volume":"51","author":"Szechtman","year":"1999","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0100","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1017\/S146114571200154X","article-title":"Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity","volume":"16","author":"Sesia","year":"2013","journal-title":"Int. J. Neurospychopharmacol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0105","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1007\/s00213-014-3505-6","article-title":"Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD)","volume":"231","author":"Tucci","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2017.06.016_bib0110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00213-008-1241-5","article-title":"Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder","volume":"200","author":"Kontis","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2017.06.016_bib0115","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1007\/s00213-014-3527-0","article-title":"Differences in the structure of drinking, cart expression and dopamine turnover between polydipsic and non polydipsic rats in the quinpirole model of psychotic polydipsia","volume":"231","author":"Schepisi","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2017.06.016_bib0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.npp.1300010","article-title":"Selective alleviation of compulsive lever-pressing in rats by D1, but not D2, blockade: possible implications for the involvement of D1 receptors in obsessive-compulsive disorder","volume":"28","author":"Joel","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2017.06.016_bib0125","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","article-title":"The mysterious motivational functions of mesolimbic dopamine","volume":"8","author":"Salamone","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2017.06.016_bib0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbr.2017.06.016_bib0135","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.neuroscience.2008.01.084","article-title":"Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats","volume":"153","author":"Pioli","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2017.06.016_bib0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbr.2008.11.033","article-title":"Modeling operant behavior in the parkinsonian rat","volume":"198","author":"Avila","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2017.06.016_bib0145","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.105.085472","article-title":"Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior","volume":"314","author":"Collins","year":"2005","journal-title":"J. Parmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2017.06.016_bib0150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1146\/annurev-clinpsy-032813-153705","article-title":"Impulsive and compulsive behaviors in Parkinson\u2019s disease","volume":"10","author":"Averbeck","year":"2014","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/syn.21805","article-title":"Parkinson\u2019s disease treatment may cause impulse-control disorder via dopamine D3 receptors","volume":"69","author":"Seeman","year":"2015","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2017.06.016_bib0160","first-page":"1369","article-title":"The effect of repeated treatment with pramipexole on the central dopamine D3 system","volume":"12","author":"Maj","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2017.06.016_bib0165","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1212\/WNL.56.11.1559","article-title":"Influence of L-Dopa and pramipexole on striatal dopamine transporter in early PD","volume":"56","author":"Guttman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2017.06.016_bib0170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/npp.2008.114","article-title":"Sustained administration of pramipexole modifies spontaneous firing of dopamine, norepinephrine and serotonin neurons in the Rat brain","volume":"34","author":"Chernoloz","year":"2009","journal-title":"Neurospychopharmacology"},{"issue":"437","key":"10.1016\/j.bbr.2017.06.016_bib0175","article-title":"Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats","volume":"8","author":"Dardou","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbr.2017.06.016_bib0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pbb.2015.01.002","article-title":"The triple inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition","volume":"130","author":"Chiang","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2017.06.016_bib0185","first-page":"69","article-title":"Differential effects of dopamine receptor subtype specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule","volume":"109","author":"Engelm","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2017.06.016_bib0190","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.20757","article-title":"Compulsive eating and weight gain related to dopamine agonist use","volume":"21","author":"Nirenberg","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2017.06.016_bib0195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/FBP.0b013e32833109a0","article-title":"Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson\u2019s disease","volume":"20","author":"Fenu","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0200","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/syn.21653","article-title":"The selective D\u2083 receptor antagonist SB-277011A attenuates morphine-triggered reactivation of expression of cocaine-induced conditioned place preference","volume":"67","author":"Rice","year":"2013","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2017.06.016_bib0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainresrev.2004.12.033","article-title":"The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence","volume":"49","author":"Heidbreder","year":"2005","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbr.2017.06.016_bib0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00001756-200301200-00018","article-title":"Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference","volume":"14","author":"Gyerty\u00e1n","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2017.06.016_bib0215","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1098\/rstb.2008.0089","article-title":"Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction","volume":"363","author":"Everitt","year":"2008","journal-title":"Philos. Trans. R. Soc. Lond. Biol. Sci."},{"key":"10.1016\/j.bbr.2017.06.016_bib0220","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/npp.2009.162","article-title":"Dissociable control of impulsivity in rats by dopamine d2\/3 receptors in the core and shell subregions of the nucleus accumbens","volume":"35","author":"Besson","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2017.06.016_bib0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2012.08.005","article-title":"Reinforcing properties of Pramipexole in normal and parkinsonian rats","volume":"49","author":"Engeln","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2017.06.016_bib0230","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02935553","article-title":"The role of immediate early genes in the stabilization of long-term potentiation","volume":"5","author":"Abraham","year":"1991","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0235","first-page":"1","article-title":"C-Fos expression during temporal order judgment in mice","volume":"5","author":"Makoto","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2017.06.016_bib0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2012.09.023","article-title":"Dopaminergic modulation of synaptic transmission in cortex and striatum","volume":"76","author":"Tritsch","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2017.06.016_bib0245","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1126\/science.1234733","article-title":"Repeated cortico-striatal stimulation generates persistent OCD-like behavior","volume":"340","author":"Ahmari","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbr.2017.06.016_bib0250","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.1232380","article-title":"Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors","volume":"340","author":"Brugui\u00e8re","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbr.2017.06.016_bib0255","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0896-6273(00)00113-6","article-title":"Toward a neurobiology of obsessive-compulsive disorder","volume":"28","author":"Graybiel","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2017.06.016_bib0260","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","article-title":"The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry","volume":"163","author":"Robbins","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2017.06.016_bib0265","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1212\/WNL.0000000000001619","article-title":"Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease","volume":"84","author":"Carriere","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2017.06.016_bib0270","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00213-006-0387-2","article-title":"The signal attenuation rat model of obsessive-compulsive disorder: a review","volume":"186","author":"Joel","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2017.06.016_bib0275","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.fbp.0000132925.81402.0a","article-title":"\u2018Compulsive\u2019 lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam","volume":"15","author":"Joel","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nlm.2013.11.007","article-title":"Dopamine and extinction: a convergence of theory with fear and reward circuitry","author":"Abraham","year":"2014","journal-title":"Neurobio. Learn. Mem."},{"key":"10.1016\/j.bbr.2017.06.016_bib0285","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11055-008-0057-4","article-title":"The role of dopamine-dependent negative feedback in the hippocampus-basal ganglia-thalamus-hippocampus loop in the extinction of responses","volume":"38","author":"Sil\u2019kis","year":"2008","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.bbr.2017.06.016_bib0290","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.physbeh.2011.04.055","article-title":"Pathological behaviors provoked by dopamine agonist therapy of Parkinson\u2019s disease","volume":"104","author":"Ahlskog","year":"2011","journal-title":"Physiol. Behav."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817306332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817306332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:09:26Z","timestamp":1759064966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432817306332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":58,"alternative-id":["S0166432817306332"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2017.06.016","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic pramipexole treatment induces compulsive behavior in rats with 6-OHDA lesions of the substantia nigra and ventral tegmental area","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2017.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}